Proud to fund research initiatives to help kids with cancer.

Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia
Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia
Institute: Telethon Kids Institute
Recipient: Dr Rishi Kotecha
Funding: $180,000 February 2018 to January 2020
Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma
Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma
Institute: UNSW Australia
Recipient: Dr Daniel Carter
Funding: $296,428 July 2016 to June 2020
Synthetic retinoid therapy for diffuse intrinsic pontine glioma
Synthetic retinoid therapy for diffuse intrinsic pontine glioma
Institute: Children’s Cancer Institute
Recipient: Associate Professor David Ziegler
Funding: $200,000 July 2016 to June 2020
Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic
Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic
Institute: Children’s Cancer Institute
Recipient: Professor Richard Lock
Funding: $103,571 July 2017 to June 2020
International clinical trials support
International clinical trials support
Recipient: Australian and New Zealand Children’s Haematology/Oncology Group
Funding: $325,000 July 2015 to June 2020
New state-wide Children’s and Adolescent/Young Adult Cancer Clinical Trials Unit
New state-wide Children’s and Adolescent/Young Adult Cancer Clinical Trials Unit
Institute: Royal Hobart Hospital
Recipient: Associate Professor John Heath
Funding: $140,000 July 2017 to June 2019
Personalised disease monitoring in childhood AML
Personalised disease monitoring in childhood AML
Institute: University of Queensland Diamantina Institute
Recipient: Dr Andrew Moore
Funding: $474,591 July 2014 to June 2019
Personalised Medicine: Zero Childhood Cancer
Personalised Medicine: Zero Childhood Cancer
Institute: Children’s Cancer Institute
Recipient: Professor Michelle Haber
Funding: $887,250 July 2014 to June 2019
Pre-clinical development of novel immune therapy for paediatric cancers
Pre-clinical development of novel immune therapy for paediatric cancers
Institute: Children’s Cancer Institute
Recipient: Dr Alla Dolnikov
Funding: $160,000 July 2016 to June 2019
Ready, Steady, School
Ready, Steady, School
Institute: UNSW Australia
Recipient: Dr Joanna Fardell
Funding: $294,678 July 2016 to June 2019
Development of personalised medicine approaches to treat medulloblastoma
Development of personalised medicine approaches to treat medulloblastoma
Institute: QIMR Berghofer Medical Research Institute
Recipient: Dr Bryan Day
Funding: $263,960 July 2016 to June 2019
Exploring better and safer treatments for osteosarcoma
Exploring better and safer treatments for osteosarcoma
Institute: La Trobe University
Recipient: Associate Professor Christine Hawkins
Funding: $382,713 July 2016 to June 2019
Improving chemotherapy regimens for medulloblastoma
Improving chemotherapy regimens for medulloblastoma
Institute: Telethon Kids Institute
Recipient: Dr Nick Gottardo
Funding: $252,987 July 2016 to June 2018
Next gen sequencing to identify gene mutations in childhood cancer patients
Next gen sequencing to identify gene mutations in childhood cancer patients
Institute: The Children's Hospital at Westmead
Recipient: Professor Jennifer Byrne and Dr Luciano Dalla-Pozza
Funding: $75,000 July 2017 to June 2018
Novel therapies for diffuse intrinsic pontine glioma (DIPG)
Novel therapies for diffuse intrinsic pontine glioma (DIPG)
Institute: Children’s Cancer Institute
Recipient: Associate Professor David Ziegler
Funding: $260,642 July 2016 to June 2018
Together we can end childhood cancer.
The only way to improve outcomes for children with cancer is through advances in medical research. Every day and every donation takes us closer to a cure.
Select your donation details
Please enter the amount you would like to donate
Be a hero and make a difference for kids with cancer today!